Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This observational study will seek to investigate the following questions in women with lipoedema:
Lipoedema is a chronic adipose tissue disorder that occurs almost exclusively in women and affects approximately 11% worldwide. Pain is a recurring feature described by people with lipoedema (pwL) with a recent study reporting 88.3% of patients indicating pain as a clinical feature. It has been suggested, with chronic long-term conditions, that the pain people experience can be moulded by a myriad of elements.This includes biomedical, psychosocial (e.g. patients' beliefs, expectations, and mood), and behavioural factors (e.g. context, responses by significant others). PwL often experience significant impairment in their daily activities and quality of life. It has further been found that psychological and the biomedical consequences of lipoedema can increase the chances of anxiety and depression which can subsequently further impact on quality of life and pain experience.
This observational study will seek to investigate the following questions in women with lipoedema:
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Women with Lipoedema | No interventions administered. |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Brief Pain Inventory - short form | The Brief Pain Inventory - Short Form is a simple, 9 question self-reporting tool that expands on other questionnaires such as the McGill pain questionnaire which focuses more on the quality of pain. The questionnaire allows the individual to rate the severity of pain and it also looks at how pain affects daily functions and discloses the site of pain in the past 24 hours. Within the questionnaire there are four severity questions looking at pain 'at least', 'at worst' (both in the last 24 hours), 'on average' and 'now' using a Likert scale with 0 = no pain to 10 = pain as bad as you can imagine. Seven pain interference domains are also included in the questionnaire covering general activity, mood, walking ability, normal work, relations with others, sleep and enjoyment of life. These are also measured on a Likert scale with 0 = no interference to 10 = interferes completely. | Only once at participation, the study duration is approximately 2 years |
| Measure | Description | Time Frame |
|---|---|---|
| Symptoms severity scale | Symptom severity will be recorded using a 5 - point Likert scale with 1 = no problem to 5 = extremely severe. These symptoms include:
| During study, only once at participation - 2 years |
| Measure | Description | Time Frame |
|---|---|---|
| Demographic questionnaire | Data for the following variables will be collected from the participants:
| Only once at participation, the study duration is approximately 2 years |
Inclusion Criteria:
Exclusion Criteria:
- Inability to provide consent
Participant eligibility is based on self-representation of gender identity.
Not provided
Women with lipoedema.
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Chee Wee Tan, PhD | Contact | +44 (0)141 331 8038 | cheeweetan.uk@gcu.ac.uk |
| Name | Affiliation | Role |
|---|---|---|
| Chee Wee Tan, PhD | Glasgow Caledonian University | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Glasgow Caledonian University | Recruiting | Glasgow | United Kingdom |
Not provided
| ID | Term |
|---|---|
| D065134 | Lipedema |
| D010146 | Pain |
| ID | Term |
|---|---|
| D003240 | Connective Tissue Diseases |
| D017437 | Skin and Connective Tissue Diseases |
| D009461 | Neurologic Manifestations |
| D012816 | Signs and Symptoms |
Not provided
Not provided
Not provided
Not provided
Not provided
| Depression, Anxiety and Stress Scale - 21 | The Depression, Anxiety and Stress Scale - 21 is a a self-reporting questionnaire with three scales measuring three negative emotional states: depression, anxiety, and stress. Within the questionnaire, each of the three scales contain 7 items with the scores of these items totalled. Each item is score on a likert scale of 0 to 3: 0 being ' did not apply to me at all', 1 being 'applied to me to some degree, or some of the time, 2 being 'applied to me to a considerable degree' or a good part of the time', 3 being 'applied to me very much or most of the time'. | Only once at participation, the study duration is approximately 2 years |
| World Health Organization Quality of Life Assessment | The World Health Organization Quality of Life Assessment is a shorter version of the initially developed questionnaire with 100 items, with this shorter version containing 26 items. It measures the broad domains of physical health, psychological health, social relationships, and environment. For each of these domains a mean score is produced for use within research and analysis. The items are rated on a 5-point Likert scale (low score of 1to high score of 5) to determine the raw item score. The the mean for each domain is calculated. After which, the domain score is multiplied by 45 to transform the domain score into a scaled score. A high score indicates a higher quality of life. | Only once at participation, the study duration is approximately 2 years |
| D013568 | Pathological Conditions, Signs and Symptoms |